MSF Field Research > 1 Published Research and Commentary > TB > Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/235558
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
18 . Issikidas P et al MDR TB side effects PlosOne.pdf86KbAdobe PDF

Title: Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.
Authors: Isaakidis, Petros
Varghese, Bhanumati
Mansoor, Homa
Cox, Helen S
Ladomirska, Joanna
Saranchuk, Peter
Da Silva, Esdras
Khan, Samsuddin
Paryani, Roma
Udwadia, Zarir
Migliori, Giovanni Battista
Sotgiu, Giovanni
Reid, Tony
Affiliation: Médecins Sans Frontières, Mumbai, India.
Citation: Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. 2012, 7 (7):e40781 PLoS ONE
Publisher: PLoS
Journal: PloS One
Issue Date: Jul-2012
URI: http://hdl.handle.net/10144/235558
DOI: 10.1371/journal.pone.0040781
PubMed ID: 22792406
Abstract: Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.
Language: en
ISSN: 1932-6203
Rights: Published by Public Library of Science, http://www.plosone.org/ Archived on this site by Open Access permission
Appears in topics: TB

Related articles on PubMed
bullet
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India.
Isaakidis P, Cox HS, Varghese B, Montaldo C, Da Silva E, Mansoor H, Ladomirska J, Sotgiu G, Migliori GB, Pontali E, Saranchuk P, Rodrigues C, Reid T
2011
bullet
Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.
Isaakidis P, Paryani R, Khan S, Mansoor H, Manglani M, Valiyakath A, Saranchuk P, Furin J
2013
bullet
'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.
Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T, Kielmann K
2013 Sep
bullet
Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, Friedman H, Bisson GP
2013 Mar
bullet
See all 194 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Apr 18, 2014